Financiere de Tubize (XBRU:TUB) Debt-to-Equity : 0.04 (As of Dec. 2023)

View and export this data going back to 1985. Start your Free Trial

What is Financiere de Tubize Debt-to-Equity?

Financiere de Tubize's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €79.20 Mil. Financiere de Tubize's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.00 Mil. Financiere de Tubize's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €1,796.59 Mil. Financiere de Tubize's debt to equity for the quarter that ended in Dec. 2023 was 0.04.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Financiere de Tubize's Debt-to-Equity or its related term are showing as below:

XBRU:TUB' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.05 Max: 0.15
Current: 0.04

During the past 13 years, the highest Debt-to-Equity Ratio of Financiere de Tubize was 0.15. The lowest was 0.01. And the median was 0.05.

XBRU:TUB's Debt-to-Equity is ranked better than
76.8% of 1069 companies
in the Biotechnology industry
Industry Median: 0.15 vs XBRU:TUB: 0.04

Financiere de Tubize Debt-to-Equity Historical Data

The historical data trend for Financiere de Tubize's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Financiere de Tubize Debt-to-Equity Chart

Financiere de Tubize Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.03

0.01

0.03

0.04

Financiere de Tubize Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.01	0.01	0.03	0.03	0.04

Competitive Comparison of Financiere de Tubize's Debt-to-Equity

For the Biotechnology subindustry, Financiere de Tubize's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Financiere de Tubize's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Financiere de Tubize's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Financiere de Tubize's Debt-to-Equity falls into.

Financiere de Tubize Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Financiere de Tubize's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(79.2	+	0)	/	1796.594
	=	0.04

Financiere de Tubize's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(79.2	+	0)	/	1796.594
	=	0.04

Financiere de Tubize (XBRU:TUB) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Financiere de Tubize Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Financiere de Tubize's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Financiere de Tubize (XBRU:TUB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Financiere de Tubize SA (XBRU:TUB) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

FTD:Germany

Address

Allée de la Recherche, 60, Brussels, BEL, 1070

Website

https://www.financiere-tubize.be

Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a global biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Most of its sales revenue is derived from its neurology products, followed by its immunology products. The company's strategy focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.

Financiere de Tubize (XBRU:TUB) Headlines

No Headlines